MyFinsight
Home
About
Contact
Back
Income Statement
HALOZYME THERAPEUTICS, INC. (HALO)
source: myfinsight.com
Download
Download image
Device Licensing And
Development
$4,070K
Event Based
Development And Regulatory...
$24,500K
Sales Based Milestone
$10,000K
Bulkr Hu PH20
$23,271K
Device Partnered
Products
$11,787K
Proprietary Products Sales
$46,452K
Collaborative Agreements
$38,570K
Product
$81,510K
Royalty
$205,639K
Total revenues
$325,719K
(40.79%↑ Y/Y)
Operating income
$202,441K
(72.68%↑ Y/Y)
Investment and other
income, net
$6,891K
(36.94%↑ Y/Y)
Total operating
expenses
$123,278K
(8.03%↑ Y/Y)
Income before income
tax expense
$204,938K
(74.06%↑ Y/Y)
Interest expense
$4,394K
(-2.87%↓ Y/Y)
Amortization of intangibles
$17,762K
(0.00%↑ Y/Y)
Cost of sales
$46,359K
(17.05%↑ Y/Y)
Research and development
$17,543K
(-16.61%↓ Y/Y)
Selling, general and
administrative
$41,614K
(16.53%↑ Y/Y)
Net income
$165,160K
(77.12%↑ Y/Y)
Income tax expense
$39,778K
(62.37%↑ Y/Y)
Back